Home » Newsletters » BioWorld Science

BioWorld Science

May 12, 2022

View Archived Issues

Inflammation is key to preventing chronic pain, study finds

Microglial MIR155 targeting ameliorates vasculopathy in retina of AD models

Loss of angpt1 recapitulates glaucoma features

Kumquat Biosciences patents SOS1/KRAS interaction inhibitors

Sichuan Haisco Pharmaceutical divulges new JAK inhibitors

Rheos Medicines identifies new MALT1 inhibitors

Gilead Sciences presents new compounds for viral infections

New PROTACs presented by C4 Therapeutics

PEGylation of bispecific antibody IGT-427 improves potential for treating retinal diseases

Targeting bromodomain in Brg-1 unveiled as a promising approach for uveal melanoma

GT-02329 shows promise in in vitro and in vivo Gaucher disease models

Myrtelle launches new research program for Pelizaeus-Merzbacher disease

CRB-601 shows promising antitumor activity alone or in combination with immunotherapy

Aro's Centyrin-targeted siRNA conjugates show potential for Pompe disease

Inimmune develops TLR7/8 agonist for monotherapy or combination with anti-PD-1 therapy

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...